Wet granulation of veterinary anthelmintic tablet blends uses ethanol as the liquid bridge phase when the active compound is hydrolytically unstable in aqueous systems. Praziquantel- and fenbendazole-containing tablet cores for companion animals are granulated with ethanol at 6–12% w/w of the dry blend in a top-spray high-shear granulator, using an impeller tip speed of 2–6 m/s and a chopper speed of 1500–3000 rpm to prevent overwetting. The binder, typically povidone K30 or hydroxypropyl methylcellulose, is dissolved in ethanol 96% v/v before addition; water content remains below 0.5% to limit hydrate formation in the API. The lower surface tension of ethanol (22.1 mN/m at 20 °C, compared with 72.8 mN/m for water) improves particle wetting and reduces binder migration to granule surfaces. Drying is performed in an explosion-proof fluidised-bed dryer with inlet air temperature 50–60 °C, product temperature 28–34 °C, and airflow 0.8–1.5 m/s. Residual ethanol after drying is controlled to ≤5000 ppm by headspace gas chromatography according to USP 467 Option 1, and the final tablet hardness is maintained at 60–100 N with friability not exceeding 1.0% under Ph. Eur. 2.9.7. Terminal tablets are film-coated in a pan coater using an aqueous or hydroalcoholic seal coat; where a hydroalcoholic top coat is used, explosion-proof extraction and LEV are mandatory. Compliance requires adherence to 21 CFR 210.3 and 211.67 for equipment cleaning and batch records, with solvent recovery or thermal oxidation of dryer exhaust to keep workplace ethanol vapour below 1000 ppm as an 8-hour TWA.

What Restricts Ethanol Co-Solvent Loading in Injectable Veterinary Formulations?

In parenteral veterinary products, ethanol is rarely used as the sole vehicle because of injection-site pain, hemolysis risk, and volatility during aseptic processing. Where an API with poor aqueous solubility requires a water-miscible cosolvent, ethanol is incorporated at 5–10% v/v in small-volume injectable solutions, and the upper limit for intramuscular use is generally not more than 15% v/v to avoid precipitation upon aqueous dilution in tissue. Published data for specific commercial injectable veterinary formulations containing ethanol is limited, and use is confined to products where the dose volume is below 10 mL per injection site. Formulation development follows USP 1 Injections and USP 85 Bacterial Endotoxins, with ethanol affected by depyrogenation constraints: ethanol cannot be dry-heat sterilised at 250 °C without boiling, so the entire solution is filtered through a 0.22 μm PVDF or PES membrane and aseptically filled under Grade A laminar flow. Bubble point testing of the filter is performed to confirm a minimum bubble point according to ASTM F838-20. Ethanol-water mixtures reduce surface tension to 35–45 mN/m at 20 °C compared with pure water at 72.8 mN/m, which can improve filter wetting but may extract leachables from uncoated rubber closures; therefore closures are ethylene tetrafluoroethylene coated or PTFE faced. Terminal steam sterilisation is generally avoided because ethanol vapour pressure at 121 °C exceeds the pressure rating of standard sealed ampoules. Residual solvent control for injectables follows VICH GL18 and USP 467, but because ethanol is a deliberate excipient rather than an impurity, it is listed in the product specification as an assay ingredient rather than an unspecified residue. Finished injectable solutions are stored at 2–8 °C to reduce volatility, and container headspace is kept below 5% oxygen to prevent aldehyde formation.

In hard capsule production for companion-animal parasiticides, ethanol is used as a low-residue solvent for spray-dried API layering onto sugar spheres. Ethanol 96% v/v is blended with purified water at 70:30 to 85:15 volume ratio to dissolve the API and binder, based on the solubility profile of the active. The spray suspension is applied to starch/sucrose pellets in a Wurster coater at inlet air temperature 45–55 °C, product temperature 32–38 °C, and spray rate 5–15 g/min/kg of substrate. The solvent ratio is reduced stepwise from ethanol-rich to water-rich during the final phase to minimise residual ethanol and prevent pellet agglomeration. Capsule fill mass is then filled into size 0 or size 1 hard gelatin capsules on a dosator or tamping-pin capsule filler; fill weight variation is controlled to ±5% of target. Hard capsule shells exposed to high ethanol concentrations can lose moisture and become brittle; therefore the shell moisture is kept at 13–16% w/w and filling rooms are maintained at 20–25 °C and 35–45% RH. Residual ethanol in the finished capsules is limited to ≤5000 ppm by headspace GC according to USP 467, and the final product is tested for dissolution using USP 711 with apparatus 2 at 50 rpm in 0.1 M hydrochloric acid. Compliance for packaging includes 21 CFR 211.166 stability testing; ethanol is recorded as a processing aid excipient in the master formula.

When Ethanol Replaces Aqueous Binder Solution in Water-Soluble Drinking Water Powders

Water-soluble veterinary powders for mass medication of poultry or swine via drinking water often contain effervescent couples, hygroscopic vitamins, or moisture-sensitive amoxicillin trihydrate; aqueous granulation can initiate premature hydrolysis or caking. Ethanol is applied at 4–8% w/w of the dry blend in a plough mixer or single-screw granulator to form granules without activating effervescent systems or causing crystal growth. The ethanol dissolves polyvinylpyrrolidone K25 to create a low-viscosity binder solution of 20–60 mPa·s at 20 °C, which is sprayed through a 0.8 mm nozzle at 2–4 bar atomising pressure onto a powder bed of lactose monohydrate and anhydrous citric acid. Wet mass is discharged and dried in a vacuum dryer at 40–50 °C and −0.8 bar to prevent thermal degradation; residual ethanol is confirmed below 0.5% w/w in batches before milling. The granules are passed through a 1.0 mm screen and blended with flavour and flow aids. Finished powders are packed into low-moisture barrier foil sachets under ≤30% RH. Terminal products are tested for ethanol residue using gas chromatography with flame ionisation detection according to USP 467 Option 1 and for water content by USP 921. Explosion prevention includes nitrogen blanketing in the dryer, oxygen monitoring below 8% v/v, and all electrical panels rated for Zone 1 per ATEX 2014/34/EU.

Granulated feed top-dress products for grower-finisher pigs use ethanol at 6–10% w/w of dry solids to agglomerate fine particles of calcium butyrate, fumaric acid, and carrier oils into free-flowing granules. The non-aqueous solvent prevents acid-catalysed hydrolysis and controls dust without dissolving water-soluble binders. Granulation is carried out in a high-shear mixer with an impeller torque endpoint of 30–40% of motor load; wet mass is then extruded through a 1.5 mm screen and spheronised at 300–600 rpm for 3–6 min. Drying at 50–60 °C reduces residual ethanol to ≤2000 ppm because these granules are used in feed at high inclusion rates and must not contribute to feed alcohol content. Particle size distribution after drying is controlled to 0.8–1.6 mm and fines below 10% to avoid segregation in spiral mixers. The terminal granules are bulk-packed in 25 kg woven polypropylene bags with an inner PE liner. Analytical release includes sieve analysis according to Ph. Eur. 2.9.38 and ethanol residue by headspace GC. Process safety is governed by NFPA 30 handling of flammable liquids, with local exhaust ventilation maintaining vapour concentration below 25% of LEL.

Explosion-Proof Fluid-Bed Spraying of Ethanol-Based Premix onto Feed-Grade Carriers

Liquid premix manufacture for medicated feed articles requires uniform distribution of low-dose active compounds onto feed-grade carriers such as ground corn cobs, wheat middlings, or calcium carbonate. Ethanol dissolves lipophilic APIs at 20–30% w/w of solution mass before the solution is sprayed onto a moving carrier at 5–15 L/100 kg carrier. The use of ethanol instead of vegetable oil shortens subsequent drying and avoids rancidity, but demands a closed-loop fluid-bed or ribbon-blender arrangement with inert gas recirculation. In a 500 kg ribbon blender, spray nozzles of 0.5 mm diameter at 1.5–3.0 bar atomising pressure deliver a droplet size of 20–50 μm, and the carrier bed is kept at 20–25 °C to prevent ignition. Quantitative distribution is verified by sampling 10 cross-section points and testing for active content by HPLC; homogenisation requires a relative standard deviation of not more than 5% for the active marker. The finished premix is packed after solvent stripping to ≤1000 ppm ethanol in the final carrier, measured by headspace GC. This residual ethanol limit is lower than the general Class 3 solvent guideline because the premix is incorporated into animal feed where multiday consumption may exceed 10 g of total daily premix. Compliance falls under 21 CFR 225 for medicated feed manufacturing and 21 CFR 226 for Type A medicated articles in the US; ATEX 2014/34/EU and NFPA 30 govern the flammable-liquid handling. Batch records must include maximum working temperature of the ethanol solution, which shall be at least 10 °C below the ethanol flash point of 13 °C, and continuous LEL monitoring with automatic shutdown at 25% LEL.

Oral Drench Solutions, Ruminant Saliva Dilution, and Ethanol Solubilization Thresholds

Ethanol in oral drench solutions for sheep and cattle functions as a co-solvent for poorly water-soluble actives and as a low-level viscosity modifier; it does not act as a preservative at concentrations below 10% v/v. Oral drench vehicles are formulated with ethanol at 5–20% v/v in propylene glycol or glycerin co-solvent systems, with example APIs being macrocyclic lactones or benzimidazole compounds requiring non-aqueous dissolution. The final solution is filled into HDPE or aluminium-foil laminate pack sizes of 250 mL, 1 L, or 5 L and dosed via an oral dosing gun. Ruminant saliva dilutes the drench rapidly, so precipitation risk must be evaluated by dilution testing in simulated saliva at 37 °C; a common target is no visible precipitation at 1:10 dilution after 30 min. Because ethanol is fermented in the rumen, the total ethanol delivered per animal should remain below 0.5 mL/kg bodyweight in a single drench to avoid transient central nervous effects and rumen dysbiosis; published toxicological threshold data for ethanol in ruminant oral dosing is limited, and this limit is based on conservative formulation practice rather than a harmonised regulatory limit. Terminal solutions are tested for ethanol assay by USP 611 alcohol determination, viscosity by Ph. Eur. 2.2.9, and microbial enumeration by Ph. Eur. 2.6.12. Storage below 25 °C in closed containers is required because ethanol loss through semi-permeable pack materials changes the co-solvent capacity. Compliance with 21 CFR 211.166 stability protocols is required for the finished oral solution, and the label must state ethanol content where it exceeds 10% v/v for target-species safety.